Traitement de recours dans l’insuffisance cardiaque avancée

Dickstein K, Cohen-Solal A, Filippatos G, et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–442 McMurray JJ, Adamopoulos S, Anker SD, et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–847 Writing Committee Members, Yancy CW, Jessup M, et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:e240–e327 Metra M, Ponikowski P, Dickstein K, et al (2007) Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 9:684–94 Aaronson KD, Schwartz JS, Chen TM, et al (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95:2660–7 Levy WC, Mozaffarian D, Linker DT, et al (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113:1424–33 Nagarajan V, Tang WH(2011) Biomarkers in advanced heart failure: diagnostic and therapeutic insights. Congest Heart Fail 17:169–74 Holman WL(2012) Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS): what have we learned and what will we learn? Circulation 126:1401–6 Stevenson LW, Pagani FD, Young JB, et al (2009) INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 28:535–41 Heart Failure Society of America, Lindenfeld J, Albert NM, et al (2010) HFSA 2010 Comprehensive heart failure practice guideline. J Card Fail 16:e1–e194 Carpentier A, Latrémouille C, Cholley B, et al (2015) First clinical use of a bioprosthetic total artificial heart: report of two cases. Lancet [in press] Obadia JF, Armoiry X, Iung B, et al (2015) The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol 10:1354–60 Beurtheret S, Mordant P, Paoletti X, et al (2013) Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE Program). Eur Heart J 34:112–20 Lévy B, Bastien O, Bendjelid K, et al (2014) Prise en charge du choc cardiogénique chez l’adulte. Réanimation 23:548–57 Combes A, Leprince P, Luyt CE, et al (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36:1404–11 European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 12:1360–420 Singh TP, Almond CS, Semigran MJ, et al (2012) Risk prediction for early in-hospital mortality following heart transplantation in the United States. Circ Heart Fail 5:259–66 Ronco C, Kaushik M, Valle R, et al (2012) Diagnosis and management of fluid overload in heart failure and cardiorenal syndrome: the “5B” approach. Semin Nephrol 32:129–41 Bart BA, Goldsmith SR, Lee KL, et al (2012) Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367:2296–304 no author] (2012) Summary of Recommendation Statements. Kidney Int Suppl 2:8–12 Ronco C, Cicoira M, McCullough PA(2012) Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 60:1031–42 Goursaud S, du Cheyron D (2014) Le syndrome cardiorénal: diagnostic, physiopathologie et prise en charge. Réanimation 23:585–94 Agence de la biomédecine (2014) Procédures d’application des règles de répartition et d’attribution des greffons prélevés sur personne décédée. Disponible: http://www.agence-biomedecine.fr/IMG/pdf/regles_repartition_organes_decembre2013.pdf Rihal CS, Naidu SS, Givertz MM, et al (2015) 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of value by the Canadian Association of Interventional Cardiology — Association canadienne de cardiologie d’intervention). Catheter Cardiovasc Interv 85:E175–E96 Russell SD, Rogers JG, Milano CA, et al (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120:2352–7 Demirozu ZT, Etheridge WB, Radovancevic R, Frazier OH(2011) Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 30:182–7 Paden ML, Conrad SA, Rycus PT(2013) Extracorporeal Life Support Organization Registry Report 2012. ASAIO J Am Soc Artif Intern Organs 1992 59:202–10 Lawson WE, Koo M (2015) Percutaneous ventricular assist devices and ECMO in the management of acute decompensated heart failure. Clin Med Insights Cardiol 9:41–8 Abrams DC, Prager K, Blinderman CD, et al (2014) Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. Chest J 145:876 Agence de la biomédecine (2013) Greffe cardiaque — rapport médical et scientifique. Disponible: http://www.agence-biomedecine.fr/annexes/bilan2013/donnees/sommaire-organes.htm Stehlik J, Edwards LB, Kucheryavaya AY, et al (2010) The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report — 2010. J Heart Lung Transplant 29:1089–103 Mehra MR, Kobashigawa J, Starling R, et al (2006) Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation Guidelines for the care of cardiac transplant candidates — 2006. J Heart Lung Transplant 25:1024–42 Gilotra NA, Russell SD(2013) Patient selection for mechanical circulatory support. Heart Fail Rev 18:27–34 Mikus E, Stepanenko A, Krabatsch T, et al (2011) Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decisionmaking? Eur J Cardiothorac Surg 39:310–6 Zimpfer D, Zrunek P, Sandner S, et al (2007) Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg 31:698–702 Lund LH, Edwards LB, Kucheryavaya AY, et al (2013) The Registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report — 2013; focus theme: age. J Heart Lung Transplant 32:951–64 Kirklin JK, Naftel DC, Pagani FD, et al (2014) Sixth INTERMACS annual report: a 10, 000-patient database. J Heart Lung Transplant 33:555–64 Kirklin JK, Naftel DC, Kormos RL et al (2012) The Fourth INTERMACS Annual Report: 4, 000 implants and counting. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 31:117–26 Ochiai Y, McCarthy PM, Smedira NG, et al (2002) Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 106: I198–I202 Hayek S, Sims DB, Markham DW, et al (2014) Assessment of right ventricular function in left ventricular assist device candidates. Circ Cardiovasc Imaging 7:379–89 Lam KM, Ennis S, O’Driscoll G, et al (2009) Observations from non-invasive measures of right heart hemodynamics in left ventricular assist device patients. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 22:1055–62 Matthews JC, Koelling TM, Pagani FD, Aaronson KD(2008) The right ventricular failure risk score a preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51:2163–72 Rudski LG, Lai WW, Afilalo J, et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 23:685–713 Raina A, Seetha Rammohan HR, Gertz ZM, et al (2013) Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters. J Card Fail 19:16–24 Deswarte G, Kirsch M, Lesault PF, et al (2010) Right ventricular reserve and outcome after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 29:1196–8 Potapov EV, Stepanenko A, Dandel M, et al (2008) Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant 27:1275–81 Roussel JC, Sénage T, Baron O, et al (2009) CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients. Ann Thorac Surg 87:124–9 (discussion 130) van Deursen VM, Damman K, Hillege HL, et al (2010) Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 16:84–90 Kim MS, Kato TS, Farr M, et al (2013) Hepatic dysfunction in ambulatory patients with heart failure. J Am Coll Cardiol 61:2253–61 Yang JA, Kato TS, Shulman BP, et al (2012) Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant 31:601–10 Demirozu ZT, Hernandez R, Mallidi HR, et al (2014) HeartMate II left ventricular assist device implantation in patients with advanced hepatic dysfunction. J Card Surg 29:419–23 Matthews JC, Pagani FD, Haft JW, et al (2010) Model for End- Stage Liver Disease Score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 121:214–20 Kirklin JK, Naftel DC, Kormos RL, et al (2013) Fifth INTERMACS Annual Report: risk factor analysis from more than 6, 000 mechanical circulatory support patients. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 32:141–56 Cowger J, Sundareswaran K, Rogers JG, et al (2013) Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate IIRisk Score. J Am Coll Cardiol 61:313–21